Evidence map›Paper›PMID 37060396›Full record

SynthesisHigh blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension2023

Risk of Incident New-Onset Arterial Hypertension After COVID-19 Recovery: A Systematic Review and Meta-analysis.

Marco Zuin, Gianluca Rigatelli, Claudio Bilato, Giampaolo Pasquetto, Alberto Mazza

Open access · bronzeAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
6.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Risk of Arterial Hypertension After COVID-19 Recovery.High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension · 2023
    Article
  18. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Marco ZuinDepartment of Translational Medicine, University of Ferrara, Via Aldo Moro 8, 44124, Ferrara, Italy. zuinml@yahoo.it.ORCID http://orcid.org/0000-0002-4559-1292
Gianluca RigatelliDepartment of Cardiology, Ospedali Riuniti Padova Sud, Monselice, Italy.
Claudio BilatoDepartment of Cardiology, Arzignano General Hospital, Vincenza, Italy.
Giampaolo PasquettoDepartment of Cardiology, Ospedali Riuniti Padova Sud, Monselice, Italy.
Alberto MazzaDepartment of Internal Medicine, Ospedale S. Maria degli Angeli, Adria, Italy.
Azienda Ospedaliero Universitaria Ospedali Riuniti · ITAzienda Ospedaliera Santa Maria Degli Angeli · ITYahoo (United Kingdom) · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionArterial Hypertension (HT) has been described as a common comorbidity and independent risk factor of short-term outcome in COVID-19 patients. However, data regarding the risk of new-onset HT during the post-acute phase of COVID-19 are scant.

aimWe assess the risk of new-onset HT in COVID-19 survivors within one year from the index infection by a systematic review and meta-analysis of the available data.

methodsData were obtained searching MEDLINE and Scopus for all studies published at any time up to February 11, 2023, and reporting the long-term risk of new-onset HT in COVID-19 survivors. Risk data were pooled using the Mantel-Haenszel random effects models with Hazard ratio (HR) as the effect measure with 95% confidence interval (CI). Heterogeneity among studies was assessed using I

resultsOverall, 19,293,346 patients (mean age 54.6 years, 54.6% males) were included in this analysis. Of them, 758,698 survived to COVID-19 infection. Over a mean follow-up of 6.8 months, new-onset HT occurred to 12.7 [95% CI 11.4-13.5] out of 1000 patients survived to COVID-19 infection compared to 8.17 [95% CI 7.34-8.53] out of 1000 control subjects. Pooled analysis revealed that recovered COVID-19 patients presented an increased risk of new-onset HT (HR 1.70, 95% CI 1.46-1.97, p < 0.0001, I

conclusionsOur findings suggest that new-onset HT represents an important post-acute COVID-19 sequelae.

Indexed as

COVID-19HypertensionNeoplasmsComorbidityFemaleHumansMaleMiddle AgedRisk FactorsArterial hypertensionCOVID-19Follow-upLong COVID

Identifiers

PMID37060396
PMCPMC10105348
OpenAlexW4365811067

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.